From a problem to a business opportunity-design of pharmaceuticals for environmental biodegradability

Klaus Kümmerer

doi:10.1016/j.scp.2019.100136

From a problem to a business opportunity-design of pharmaceuticals for environmental biodegradability

Klaus Kümmerer

Professur für Nachhaltige Chemie und Stoffliche Ressourcen

Publikation: Beiträge in Zeitschriften › Übersichtsarbeiten › Forschung

41 Zitate (Scopus)

Abstract

Research of the past 20 years has demonstrated that human and veterinary pharmaceuticals are present in the environment. In addition to the parent compounds also metabolites and other transformation products formed within treatment or in the environment have been detected. In order to overcome the shortcomings of effluent and manure treatment new active compounds were designed for complete mineralization in the environment.

Originalsprache	Englisch
Aufsatznummer	100136
Zeitschrift	Sustainable Chemistry and Pharmacy
Jahrgang	12
Seitenumfang	4
ISSN	2352-5541
DOIs	https://doi.org/10.1016/j.scp.2019.100136
Publikationsstatus	Erschienen - 06.2019

Fachgebiete und Schlagwörter

Nachhaltigkeitswissenschaft
Chemie

ASJC Scopus Sachgebiete

Pharmazeutische Wissenschaften
Umweltverschmutzung
Umweltchemie
Management, Monitoring, Politik und Recht

Zugriff auf Dokument

10.1016/j.scp.2019.100136

2 Abgeschlossen

DBU Antibiotikum: Entwicklung eines umweltverträglichen Antibiotikums
Kümmerer, K. (Wissenschaftliche Projektleiter*in), Leder, C. (Projektmitarbeiter*in) & Rastogi, T. (Projektmitarbeiter*in)
Deutsche Bundesstiftung Umwelt
01.11.14 → 30.04.18
Projekt: Forschung

Datei
NANOPHARM: Neue photokatalytisch aktive Verbundmaterialien zur Eliminierung von pharmazeutischen Reststoffen
Kümmerer, K. (Wissenschaftliche Projektleiter*in) & Schneider, M. (Projektmitarbeiter*in)
Bundesministerium für Bildung und Forschung
01.10.10 → 30.09.13
Projekt: Forschung

Dieses zitieren

@article{863aac6cfc3040c28483ff6684dc6f41,

title = "From a problem to a business opportunity-design of pharmaceuticals for environmental biodegradability",

abstract = "Research of the past 20 years has demonstrated that human and veterinary pharmaceuticals are present in the environment. In addition to the parent compounds also metabolites and other transformation products formed within treatment or in the environment have been detected. In order to overcome the shortcomings of effluent and manure treatment new active compounds were designed for complete mineralization in the environment.",

keywords = "Sustainability Science, Chemistry, Pharmaceutical, Enviroment, Water, Soil, Chemoinformatic, Sustainable development goal, targeted design",

author = "Klaus K{\"u}mmerer",

note = "The author wants to thank the involved co-workers and the Deutsche Bundesstiftung Umwelt for supporting the work with GSF (Grant 22597-31 ) and the derivatives of ciprofloxacin (Grant 30839) and the Bundesministerium for Bildung und Forschung for supporting (Grant 03X9410 ) the work with the {\ss}-blockers.",

year = "2019",

month = jun,

doi = "10.1016/j.scp.2019.100136",

language = "English",

volume = "12",

journal = "Sustainable Chemistry and Pharmacy",

issn = "2352-5541",

publisher = "Elsevier B.V.",

}

TY - JOUR

T1 - From a problem to a business opportunity-design of pharmaceuticals for environmental biodegradability

AU - Kümmerer, Klaus

N1 - The author wants to thank the involved co-workers and the Deutsche Bundesstiftung Umwelt for supporting the work with GSF (Grant 22597-31 ) and the derivatives of ciprofloxacin (Grant 30839) and the Bundesministerium for Bildung und Forschung for supporting (Grant 03X9410 ) the work with the ß-blockers.

PY - 2019/6

Y1 - 2019/6

N2 - Research of the past 20 years has demonstrated that human and veterinary pharmaceuticals are present in the environment. In addition to the parent compounds also metabolites and other transformation products formed within treatment or in the environment have been detected. In order to overcome the shortcomings of effluent and manure treatment new active compounds were designed for complete mineralization in the environment.

AB - Research of the past 20 years has demonstrated that human and veterinary pharmaceuticals are present in the environment. In addition to the parent compounds also metabolites and other transformation products formed within treatment or in the environment have been detected. In order to overcome the shortcomings of effluent and manure treatment new active compounds were designed for complete mineralization in the environment.

KW - Sustainability Science

KW - Chemistry

KW - Pharmaceutical

KW - Enviroment

KW - Water

KW - Soil

KW - Chemoinformatic

KW - Sustainable development goal

KW - targeted design

UR - https://www.scopus.com/pages/publications/85062805316

U2 - 10.1016/j.scp.2019.100136

DO - 10.1016/j.scp.2019.100136

M3 - Scientific review articles

SN - 2352-5541

VL - 12

JO - Sustainable Chemistry and Pharmacy

JF - Sustainable Chemistry and Pharmacy

M1 - 100136

ER -

From a problem to a business opportunity-design of pharmaceuticals for environmental biodegradability

Abstract

Fachgebiete und Schlagwörter

ASJC Scopus Sachgebiete

Zugriff auf Dokument

Fingerprint

Projekte

DBU Antibiotikum: Entwicklung eines umweltverträglichen Antibiotikums

NANOPHARM: Neue photokatalytisch aktive Verbundmaterialien zur Eliminierung von pharmazeutischen Reststoffen

Dieses zitieren